A carregar...
Open-label pilot study of lisdexamfetamine for cocaine use disorder
BACKGROUND: Cocaine use disorder (CUD) is a substantial public health problem with no FDA-approved medication treatments. Psychostimulants have shown promise as pharmacotherapy for CUD. Lisdexamfetamine, a novel prodrug psychostimulant, is roughly 40–50% as potent as dextroamphetamine. OBJECTIVES: T...
Na minha lista:
| Publicado no: | Am J Drug Alcohol Abuse |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8266739/ https://ncbi.nlm.nih.gov/pubmed/33797985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2021.1885677 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|